Summary
- Current Price
- As of today, MYGN price is $5.37, up +6.55% on
- Current Price All-Time High
- MYGN price is currently -92.22% below its historical high of $69.00 set on
- Market Cap
- MYGN current market cap is $507M, up +34.51% over the past 365 days
- Revenue
- MYGN current annual revenue is $824.50M, down -1.56% year-over-year
- Next Earnings
- As of today, the next earnings release for MYGN has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Myriad Genetics, Inc. |
| Ticker | NASDAQ: MYGN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | myriad.com |
| Employees | 2,700 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $5.37 | |
| Price, 1D Change | +6.55% | |
| $507M | ||
| - | ||
| - | ||
| 1.37 | ||
| $825M | ||
| Revenue, 1Y Change | -1.56% | |
| -$3.95 | ||
| EPS, 1Y Change | -181.22% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.95 | ||
| EPS Estimate | N/A | $0.05 |
| EPS Est. Change | N/A | +101.21% |
| $824.50M | ||
| Revenue Estimate | N/A | $863.56M |
| Revenue Est. Change | N/A | +4.74% |
| Current Price | $5.37 | |
| Price Target | - | $5.75 |
| Price Tgt. Change | - | +7.08% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.13 | -$1.41 | -1,167.71% | |
| $0.00 | -$3.95 | -101,417.95% | |
| $0.05 | N/A | +101.21% | |
| $0.15 | N/A | +103.82% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $837.35M | $837.60M | +0.03% | |
| $822.69M | $824.50M | +0.22% | |
| $863.56M | N/A | +4.74% | |
| $915.82M | N/A | +11.08% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $5.37 | |
| $5.62 | ||
| $5.05 | ||
| $5.75 | ||
| $5.28 | ||
| $0.04 | ||
| 1.37 | ||
| $0.31 | ||
| 46.77 | ||
| 54.12% | ||
| 78.50% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $824.50M | ||
| -$3.95 | ||
| $576.60M | ||
| 69.93% | ||
| -$67.80M | ||
| -8.22% | ||
| -$365.90M | ||
| -44.38% | ||
| -$13.60M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.57 | ||
| 2.49 | ||
| 2.26 | ||
| - | ||
| 4 | ||
| -0.14 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 0.61 | ||
| 1.50 | ||
| -44.68 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $368.00M | ||
| $149.60M | ||
| $706.60M | ||
| $332.60M | ||
| $338.60M | ||
| $133.80M | ||
| $209.80M | ||
| $6.90M | ||
| $30.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $1.19B | ||
| $644.40M | ||
| $247.90M | ||
| $0.00 | ||
| $53.70M | ||
| $0.00 | ||
| -$29.20M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $1.80M | ||
| -$27.40M | ||
| $64.20M | ||
| $27.40M | ||
| -$25.60M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| TD Cowen | → | |
| Wells Fargo | → | |
| UBS | → | |
| Piper Sandler | → | |
| Wells Fargo | → | |
| UBS | → | |
| TD Cowen | → | |
| Scotiabank | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with MYGN
FAQ
What is the ticker symbol for Myriad Genetics, Inc.?
The ticker symbol for Myriad Genetics, Inc. is NASDAQ:MYGN
Does Myriad Genetics, Inc. pay dividends?
No, Myriad Genetics, Inc. does not pay dividends
What sector is Myriad Genetics, Inc. in?
Myriad Genetics, Inc. is in the Healthcare sector
What industry is Myriad Genetics, Inc. in?
Myriad Genetics, Inc. is in the Diagnostics & Research industry
What country is Myriad Genetics, Inc. based in?
Myriad Genetics, Inc. is headquartered in United States
When did Myriad Genetics, Inc. go public?
Myriad Genetics, Inc. initial public offering (IPO) was on October 6, 1995
Is Myriad Genetics, Inc. in the S&P 500?
No, Myriad Genetics, Inc. is not included in the S&P 500 index
Is Myriad Genetics, Inc. in the NASDAQ 100?
No, Myriad Genetics, Inc. is not included in the NASDAQ 100 index
Is Myriad Genetics, Inc. in the Dow Jones?
No, Myriad Genetics, Inc. is not included in the Dow Jones index
When was Myriad Genetics, Inc. last earnings report?
Myriad Genetics, Inc.'s most recent earnings report was on July 30, 2026
When does Myriad Genetics, Inc. report earnings?
The date for Myriad Genetics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- MYGN Official Website www.myriad.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/899923/000089992326000018/0000899923-26-000018-index.htm
- MYGN Profile on Yahoo Finance finance.yahoo.com/quote/MYGN
- MYGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mygn